Protective Effects of Ginger (Zingiber officinale) Extract against Diabetes-Induced Heart Abnormality in Rats

다국어 초록 (Multilingual Abstract)

Background: Diabetic cardiomyopathy is an important causal factor in morbidity and mortality among diabetic patients, and currently, no effective means are available to reverse its pathological progress. The purpose of the present study was to investigate the effect of ginger extract on apolipoproteins (apo) A and B, hyperhomocysteinemia, cathepsin G and leptin changes, as well as cardiac fibrosis and heart muscle cell proliferation under hyperglycemic conditions in vivo.
Methods: Twenty-four male Wistar rats were divided into three groups, namely: control, non-treated diabetic, and ginger extract-treated diabetic groups. The ginger extract-treated diabetic group received a 50 mg daily dose of ginger extract intragastrically for 6 weeks.
Results: The results revealed concurrent significant increases in plasma C-reactive protein (CRP), homocysteine (Hcy), cathepsin G and apoB levels and decreases in apoA and leptin levels in the non-treated diabetic group compared to the control group. Moreover, heart structural changes, including fibrosis and heart muscle cell proliferation, were observed in non-treated diabetic rats compared to the control rats. Significant amelioration of changes in the heart structure together with restoration of the elevated levels of Hcy and CRP, leptin, cathepsin G, and apoA and B were found in the ginger extract-treated diabetic group compared to the non-treated diabetic group.
Conclusion: The findings indicated that ginger extract significantly reduces heart structural abnormalities in diabetic rats and that these effects might be associated with improvements in serum apo, leptin, cathepsin G, and Hcy levels and with the antioxidant properties of ginger extract.

참고문헌 (Reference)

1 Shirpoor A, "Vasoprotective effect of vitamin E: rescue of ethanol-induced atherosclerosis and inflammatory stress in rat vascular wall" 16 : 498-504, 2013

2 Shirpoor A, "The protective effect of vitamin E against prenatal and early postnatal ethanol treatment-induced heart abnormality in rats: a 3-month follow-up study" 26 : 72-79, 2015

3 Rajapurohitam V, "The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes" 93 : 277-279, 2003

4 Taghizadeh Afshari A, "The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats" 101 : 148-153, 2007

5 Walldius G, "The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy: a review of the evidence" 259 : 493-519, 2006

6 Utriainen T, "Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects" 45 : 1364-1366, 1996

7 Ashcroft T, "Simple method of estimating severity of pulmonary fibrosis on a numerical scale" 41 : 467-470, 1988

8 Guzman-Ruiz R, "Sensitivity of cardiac carnitine palmitoyltransferase to malonyl-CoA is regulated by leptin: similarities with a model of endogenous hyperleptinemia" 151 : 1010-1018, 2010

9 Reilly CF, "Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases" 257 : 8619-8622, 1982

10 Shanmugam KR, "Protective effect of dietary ginger on antioxidant enzymes and oxidative damage in experimental diabetic rat tissues" 124 : 1436-1442, 2011

11 Wannamethee SG, "Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role?" 58 : 1870-1877, 2011

12 Zhao J, "Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart" 5 : 860-867, 2014

13 Gutierrez-Juarez R, "Melanocortin-independent effects of leptin on hepatic glucose fluxes" 279 : 49704-49715, 2004

14 Marcovina S, "Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels" 258 : 437-446, 2006

15 Jahanyar J, "Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart" 140 : 199-203, 2007

16 Passino C, "Markers of fibrosis, inflammation, and remodeling pathways in heart failure" 443 : 29-38, 2015

17 Zibadi S, "Leptin’s regulation of obesity-induced cardiac extracellular matrix remodeling" 11 : 325-333, 2011

18 Ahima RS, "Leptin signaling" 81 : 223-241, 2004

19 Lembo G, "Leptin induces direct vasodilation through distinct endothelial mechanisms" 49 : 293-297, 2000

20 Vecchione C, "Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway" 51 : 168-173, 2002

21 German JP, "Leptin deficiency causes insulin resistance induced by uncontrolled diabetes" 59 : 1626-1634, 2010

22 Hou N, "Leptin and cardiovascular diseases" 38 : 905-913, 2011

23 Liu HY, "Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM)" 284 : 27090-27100, 2009

24 Schram K, "Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure" 18 : 199-205, 2008

25 Soderberg S, "High leptin levels are associated with stroke" 15 : 63-69, 2003

26 Kesireddy SR., "Ginger feeding protects against renal oxidative damage caused by alcohol consumption in rats" 21 : 263-270, 2011

27 Srivastava KC, "Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders" 39 : 342-348, 1992

28 Bluestone JA, "Genetics, pathogenesis and clinical interventions in type 1 diabetes" 464 : 1293-1300, 2010

29 Alireza S, "Effects of vitamin E on pathological changes induced by diabetes in rat lungs" 185 : 593-599, 2013

30 Boden G, "Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects" 100 : 1107-1113, 1997

31 Poornima IG, "Diabetic cardiomyopathy: the search for a unifying hypothesis" 98 : 596-605, 2006

32 Shirpoor A, "Decreased blood pressure with a corresponding decrease in adhesive molecules in diabetic rats caused by vitamin E administration" 4 : 362-368, 2012

33 Westermann D, "Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism" 56 : 641-646, 2007

34 Nile SH, "Chromatographic analysis, antioxidant, anti-inflammatory, and xanthine oxidase inhibitory activities of ginger extracts and its reference compounds" 70 : 238-244, 2015

35 Kalra SP, "Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions" 29 : 127-138, 2008

36 Sweeney G, "Cardiovascular effects of leptin" 7 : 22-29, 2010

37 Shirpoor A, "Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat" 23 : 310-316, 2009

38 Okatan EN, "Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system" 24 : 2110-2118, 2013

39 McGaffin KR, "Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice" 89 : 60-71, 2011

40 Abel ED, "Cardiac remodeling in obesity" 88 : 389-419, 2008

41 Ku IA, "Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study" 217 : 503-508, 2011

42 Kolaczynski JW, "Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro" 45 : 699-701, 1996

43 Isa Y, "6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes" 373 : 429-434, 2008